Equity Research on Baxter International Inc. and Thermo Fisher Scientific Inc. - Acquisitions and R&D Driving Medical Instruments and Supplies
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 11/30/11 -- has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Medical Instruments & Supplies industry and are offering free analytical research on (NYSE: BAX) and (NYSE: TMO). Register with us today at to have free access to these research reports.
The Medical Instruments and Supplies industry have been chugging through trying economic times, with a number of companies, such as Baxter International Inc. and Thermo Fisher Scientific Inc., performing particularly well. Successful companies have managed to navigate the difficult times by growing their businesses through acquisitions and emerging markets, as well as research and development. Get your free reports on and at . There is no commitment to join.
is the Ultimate Trading Environment for investors. If you are considering owning Baxter International Inc. and Thermo Fisher Scientific Inc. then you should sign up for a free membership and our complimentary reports today at . Over the last 5 years our returns outpaced any of the major indexes. Sign up today to find out what you are missing.
Acquisitions are a quick way to expand product offerings and geographical reach, and many companies are taking this approach to expansion. Baxter recently announced it had succeeded in its planned takeover of Baxa Corp. which will help broaden Baxter's product offerings. report is accessible for free by registering today at .
Conversely, Thermo Fisher has also been actively expanding, and the acquisition of Phadia has helped grow their specialty diagnostic offerings. report is accessible for free by registering today at .
As always, research and development also remains key for companies in the Medical Instruments and Supplies industry, and receiving FDA approval for their products is paramount. A number of companies including Baxter have been reporting success in this area, and it will be interesting to see how new products affect the company's profits moving forward.
The two stocks research reports are available for free by signing up now on .
Shine's Rooms is the brain child of David Shine, a 13 year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.
To view our visit this link .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.11.2011 - 13:10 Uhr
Sprache: Deutsch
News-ID 92417
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 256 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Equity Research on Baxter International Inc. and Thermo Fisher Scientific Inc. - Acquisitions and R&D Driving Medical Instruments and Supplies"
steht unter der journalistisch-redaktionellen Verantwortung von
Shinesrooms.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
